Al Hammadi net profit falls 13% in H1 2019

28/07/2019 Argaam Exclusive

View other reports

Share Price

52.40
0.20 0.38 %

Al Hammadi Holding (ALHAMMADI)

Al Hammadi Company for Development and Investment posted a net profit after zakat and tax of SAR 44.2 million for H1 2019, a decline of 13 percent year-on-year (YoY) on higher operating expenses, administrative salaries and depreciation costs related to Nozha Hospital.



Financials (M)

Item 6m 2018 6m 2019 Change‬
Revenues 415.16 483.51 16.5 %
Gross Income 120.12 136.69 13.8 %
Operating Income 66.55 58.14 (12.6 %)
Net Income 50.81 44.18 (13.0 %)
Average Shares 160.00 160.00 -
EPS (Riyals) 0.32 0.28 (13.0 %)

The company also cited an increase in expected credit loss provision for account receivables by SAR 5.14 million in the current period, and higher finance costs.

 

The second quarter net profit after zakat and tax was almost flat at SAR 20 million, compared to net profit of SAR 19.9 million in Q2 2018 also due to higher operating expenses, subsidiary expenses, and finance costs.

 

When compared to the previous quarter, net profit dropped 17.2 percent hit by a decline in other operating income.



Current Quarter Comparison (M)

Compared With The
Item Q2 2018 Q2 2019 Change‬
Revenues 214.49 253.83 18.3 %
Gross Income 53.28 71.08 33.4 %
Operating Income 28.26 30.95 9.5 %
Net Income 19.93 20.01 0.4 %
Average Shares 160.00 160.00 -
EPS (Riyals) 0.12 0.13 0.4 %


Financial results (Million)

Period Revenues Change Gross Income Change Net Income Change EPS(Riyal)
Q1 2010 - - - - - - -
Q2 2010 - - - - - - -
Q3 2010 - - - - - - -
Q4 2010 - - - - - - -
Q1 2011 - - - - - - -
Q2 2011 - - - - - - -
Q3 2011 - - - - - - -
Q4 2011 - - - - - - -
Q1 2012 - - - - - - -
Q2 2012 - - - - - - -
Q3 2012 - - - - - - -
Q4 2012 - - - - - - -
Q1 2013 104.84 - 47.34 - 29.83 - 0.19
Q2 2013 108.85 - 45.84 - 30.06 - 0.19
Q3 2013 96.26 - 36.81 - 18.32 - 0.11
Q4 2013 124.13 - 55.17 - 33.29 - 0.21
Q1 2014 122.04 16.4 % 54.71 15.6 % 34.23 14.7 % 0.21
Q2 2014 121.66 11.8 % 53.68 17.1 % 35.60 18.4 % 0.22
Q3 2014 108.83 13.1 % 44.74 21.5 % 25.42 38.7 % 0.16
Q4 2014 129.43 4.3 % 55.99 1.5 % 33.71 1.2 % 0.21
Q1 2015 129.48 6.1 % 50.64 (7.4 %) 41.01 19.8 % 0.26
Q2 2015 137.36 12.9 % 63.56 18.4 % 36.89 3.6 % 0.23
Q3 2015 136.80 25.7 % 57.97 29.6 % 27.69 8.9 % 0.17
Q4 2015 157.70 21.8 % 68.06 21.6 % 35.75 6.0 % 0.22
Q1 2016 144.16 11.3 % 54.75 8.1 % 21.14 (48.5 %) 0.13
Q2 2016 138.08 0.5 % 57.56 (9.5 %) 20.63 (44.1 %) 0.13
Q3 2016 141.35 3.3 % 56.48 (2.6 %) 20.73 (25.1 %) 0.13
Q4 2016 182.65 15.8 % 73.35 7.8 % 10.48 (70.7 %) 0.07
Q1 2017 180.23 25.0 % 62.02 13.3 % 27.97 32.3 % 0.17
Q2 2017 176.71 28.0 % 58.16 1.0 % 25.66 24.4 % 0.16
Q3 2017 163.01 15.3 % 53.91 (4.5 %) 23.59 13.8 % 0.15
Q4 2017 188.69 3.3 % 65.08 (11.3 %) 30.76 193.4 % 0.19
Q1 2018 200.67 11.3 % 66.84 7.8 % 30.88 10.4 % 0.19
Q2 2018 214.49 21.4 % 53.28 (8.4 %) 19.93 (22.3 %) 0.12
Q3 2018 250.40 53.6 % 64.92 20.4 % 21.31 (9.7 %) 0.13
Q4 2018 228.04 20.9 % 65.32 0.4 % 17.70 (42.5 %) 0.11
Q1 2019 229.68 14.5 % 65.60 (1.9 %) 24.17 (21.7 %) 0.15
Q2 2019 253.83 18.3 % 71.08 33.4 % 20.01 0.4 % 0.13

Profitability

Period Gross Margin OIBDA Margin Net Margin Before Unusual Items
Q1 2010 - - -
Q2 2010 - - -
Q3 2010 - - -
Q4 2010 - - -
Q1 2011 - - -
Q2 2011 - - -
Q3 2011 - - -
Q4 2011 - - -
Q1 2012 - - -
Q2 2012 - - -
Q3 2012 - - -
Q4 2012 - - -
Q1 2013 - - -
Q2 2013 - - -
Q3 2013 - - -
Q4 2013 42.66 % 27.60 % 24.31 %
Q1 2014 42.66 % 27.85 % 24.35 %
Q2 2014 43.18 % 29.90 % 26.17 %
Q3 2014 43.70 % 30.34 % 26.97 %
Q4 2014 43.39 % 30.09 % 26.75 %
Q1 2015 41.90 % 29.13 % 25.73 %
Q2 2015 42.55 % 28.68 % 25.19 %
Q3 2015 42.80 % 29.71 % 24.29 %
Q4 2015 42.80 % 31.06 % 23.43 %
Q1 2016 42.42 % 30.79 % 21.09 %
Q2 2016 41.32 % 30.64 % 18.24 %
Q3 2016 40.74 % 29.96 % 16.90 %
Q4 2016 39.94 % 25.11 % 12.04 %
Q1 2017 38.83 % 24.74 % 12.43 %
Q2 2017 36.71 % 24.09 % 12.46 %
Q3 2017 35.22 % 23.41 % 12.48 %
Q4 2017 33.75 % 25.39 % 15.24 %
Q1 2018 33.46 % 26.03 % 15.21 %
Q2 2018 31.18 % 25.45 % 13.71 %
Q3 2018 29.28 % 24.60 % 12.04 %
Q4 2018 28.02 % 24.14 % 10.05 %
Q1 2019 27.00 % 22.96 % 9.01 %
Q2 2019 27.75 % 22.56 % 8.65 %


Per Share Data (Riyal)

Compared With The
Period Shares Outstanding (M) EPS (Riyal) Adjusted EPS (Riyal) Book Value (BV)
Q1 2010 - - - -
Q2 2010 - - - -
Q3 2010 - - - -
Q4 2010 - - - -
Q1 2011 - - - -
Q2 2011 - - - -
Q3 2011 - - - -
Q4 2011 - - - -
Q1 2012 - - - -
Q2 2012 - - - -
Q3 2012 - - - -
Q4 2012 - - - -
Q1 2013 160.00 - - 3.74
Q2 2013 160.00 - - 3.67
Q3 2013 160.00 - - 3.78
Q4 2013 160.00 0.70 0.66 3.66
Q1 2014 160.00 0.72 0.69 3.87
Q2 2014 160.00 0.76 0.76 7.88
Q3 2014 160.00 0.80 0.80 8.04
Q4 2014 160.00 0.81 0.81 8.25
Q1 2015 160.00 0.85 0.79 8.51
Q2 2015 160.00 0.86 0.80 8.27
Q3 2015 160.00 0.87 0.81 8.44
Q4 2015 160.00 0.88 0.82 8.66
Q1 2016 160.00 0.76 0.76 8.80
Q2 2016 160.00 0.66 0.66 8.37
Q3 2016 160.00 0.61 0.61 8.50
Q4 2016 160.00 0.46 0.46 8.56
Q1 2017 160.00 0.50 0.50 8.75
Q2 2017 160.00 0.53 0.53 8.89
Q3 2017 160.00 0.55 0.55 9.04
Q4 2017 160.00 0.67 0.67 8.67
Q1 2018 160.00 0.69 0.69 8.85
Q2 2018 160.00 0.66 0.66 8.98
Q3 2018 160.00 0.64 0.64 9.11
Q4 2018 160.00 0.56 0.56 9.24
Q1 2019 160.00 0.52 0.52 9.40
Q2 2019 160.00 0.52 0.52 9.51

Multiple Ratios (End of Period Price)

Compared With The
Period P/E Adjusted P/E Price/book
Q1 2010 - - -
Q2 2010 - - -
Q3 2010 - - -
Q4 2010 - - -
Q1 2011 - - -
Q2 2011 - - -
Q3 2011 - - -
Q4 2011 - - -
Q1 2012 - - -
Q2 2012 - - -
Q3 2012 - - -
Q4 2012 - - -
Q1 2013 - - -
Q2 2013 - - -
Q3 2013 - - -
Q4 2013 - - -
Q1 2014 - - -
Q2 2014 - - -
Q3 2014 More than 50 More than 50 5.14
Q4 2014 48.92 48.92 4.78
Q1 2015 More than 50 More than 50 5.14
Q2 2015 More than 50 More than 50 5.61
Q3 2015 44.33 47.69 4.57
Q4 2015 41.63 44.73 4.24
Q1 2016 36.41 36.41 3.14
Q2 2016 45.86 45.86 3.60
Q3 2016 36.32 36.32 2.62
Q4 2016 More than 50 More than 50 3.64
Q1 2017 More than 50 More than 50 3.50
Q2 2017 More than 50 More than 50 3.49
Q3 2017 47.94 47.94 2.91
Q4 2017 41.25 41.25 3.21
Q1 2018 39.28 39.28 3.07
Q2 2018 37.68 37.68 2.76
Q3 2018 32.21 32.21 2.27
Q4 2018 33.55 33.55 2.04
Q1 2019 35.91 35.91 1.98
Q2 2019 30.97 30.97 1.69

Business Segments (Million)

Compared With The
Period healthy services and other Pharmaceutical sales revenue - Pharmacies
Q1 2017 150.74 29.49
Q2 2017 147.45 29.26
Q3 2017 136.70 26.31
Q4 2017 155.95 32.73
Q1 2018 140.85 59.82
Q2 2018 143.64 71.39
Q3 2018 140.83 109.03
Q4 2018 154.81 73.23
Q1 2019 146.91 82.77
Q2 2019 151.05 102.78

Analysts Estimates (Million)

Item Q2 2019 (e) Q2 2019 (a) Change‬
Average 20.23 20.01 (1.1 %)

Estimates vs Actual (Million)

Item Q2 2019 (e) Q2 2019 (a) Change
AlJazira Capital 21.70 20.01 (7.8) %
SNB Capital 23.00 20.01 (13.0) %
Al Rajhi Capital 16.00 20.01 25.1 %

Current
Market Cap (M Riyal) 8,384.00
Enterprise Value (EV) (M) 8,460.43
Shares Outstanding ((M)) 160.00
EPS ( Riyal) (TTM) 1.79
Book Value (BV) ( Riyal) 11.58
Par Value ( Riyal) 10.00
Adjusted P/E (Last12) 30.00
P/E (TTM) 29.32
Price/book 4.52
Return on Average Assets (%) (TTM) 11.1
Return on Average Equity (%) (TTM) 15.9

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.